Expert Outlook: Travere Therapeutics Through The Eyes Of 6 Analysts
Expert Outlook: Travere Therapeutics Through The Eyes Of 6 Analysts
专家展望：6位分析师眼中的Travere Therapeutics
In the last three months, 6 analysts have published ratings on Travere Therapeutics (NASDAQ:TVTX), offering a diverse range of perspectives from bullish to bearish.
在过去的三个月中，有6位分析师公布了对Travere Therapeutics（纳斯达克股票代码：TVTX）的评级，提供了从看涨到看跌的不同视角。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Analysts have set 12-month price targets for Travere Therapeutics, revealing an average target of $14.83, a high estimate of $19.00, and a low estimate of $9.00. Witnessing a positive shift, the current average has risen by 4.07% from the previous average price target of $14.25.
分析师为Travere Therapeutics设定了12个月的目标股价，显示平均目标股价为14.83美元，最高估计为19.00美元，低估值为9.00美元。当前的平均价格从之前的平均目标价14.25美元上涨了4.07％，这是一个积极的转变。
Diving into Analyst Ratings: An In-Depth Exploration
深入分析师评级：深度探索
An in-depth analysis of recent...
对分析师近期...
登录免费看全文
登录/注册